Mesenchymal stem cell–derived extracellular vesicles for intratympanic injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesenchymal stem cell–derived extracellular vesicles for intratympanic injection, covering 2026-03-25 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss [Phase 1, Phase 2]